AI assistant
Sending…
Evogene Ltd. — Earnings Release 2017
Nov 22, 2017
6785_rns_2017-11-22_f5e82cd0-724a-4e1e-b1a0-d58b6f34eb1f.htm
Earnings Release
Open in viewerOpens in your device viewer
_________ false
| ����� ��"� | 2 380 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 10571 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 22/11/2017 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2017-02-103054 | Time of broadcast: 13:54 13:34:43 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onPress Release: Evogene Reports Third Quarter 2017 Financial Results
2017_Q3_FS_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 06/11/2017 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company: | |
| Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
More from Evogene Ltd.
Report Publication Announcement
2026
May 18
Regulatory Filings
2026
May 18
Foreign Filer Report
2026
May 18
Report Publication Announcement
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Apr 9
Director's Dealing
2026
Apr 9
Regulatory Filings
2026
Apr 2